We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
French authorities will begin dismantling the camp at the beginning of next week.
The woman was found wandering the streets with the skull.
The fall in the pound has not put British people off of going on holiday, with sales of the euro and the dollar up.